![]() |
|
|
Forward to a colleague |
||
Access Full Stories Thermo Fisher Scientific has acquired micro-volume UV-Vis (ultra violet visible) instrument manufacturer NanoDrop Technologies for an undisclosed amount... Read Ertl wins Nobel Prize for Chemistry Professor Gerhard Ertl of the Max-Planck Society in Berlin, Germany, has won the Nobel Prize for Chemistry on his 71st birthday for his 'groundbreaking studies in surface chemistry'... Read Product news in brief - week 41 LabTechnologist.com brings you a round up of product news, with developments at Beckman Coulter, Bruker, GE Healthcare, Invitrogen, PerkinElmer, Promega, Sigma-Aldrich, ThalesNano and Thar Instruments... Read RBM buys EDI, simplifies immune response testing Biomarker testing service provider Rules-Based Medicine (RBM) has bought EDI to gain access to its 3D organ-like and ex vivo cell culture test systems to aid its preclinical and clinical research programmes... Read Lab-on-a-chip enables cell-free protein synthesis Researchers have developed a new microfluidic device that enables high-throughput (HT), cell-free protein synthesis for genomic and proteomic functional analysis... Read |
||||||||||||||||||
All News Headlines for: October | September | August |
||||||||||||||||||
![]() Sensitive and selective with IC-MS coupling - Free Download The combination of a highly efficient ion chromatograph with a high-resolution mass spectrometer represents a modern detection technique whose strengths lie in its extreme sensitivity and excellent selectivity. IC-MS coupling is also used when matrix effects have to be... Click Here | ||||||||||||||||||
|
Related Industry News Wyeth and Zealand seek to still irregular beating heart Wyeth has begun first-in-man trials for an oral drug designed to calm an irregular heart beat, triggering a milestone payment to its partner on the project, Denmark-based Zealand Pharma... Read Emergent BioSolutions moves forward with typhoid vaccine Emergent BioSolutions is on the path to finding gold with its typhoid vaccine following positive results in a Phase II trial... Read Cosmo lands partner for world-first drug Italian firm Cosmo Pharmaceuticals today announced a licensing agreement with Ferring for its reformulated budesonide product, predicted to be the first oral corticosteroid for ulcerative colitis approved worldwide... Read Ablynx decides to go it alone with camel-based mini-antibodies Ablynx, a biopharma firm that specialises the potentially lucrative sector of miniature antibodies, has announced it plans to launch on the stock market this year... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||